Business Description
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 2.29 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.02 | |||||
Beneish M-Score | -4.99 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.5 | |||||
3-Year EPS without NRI Growth Rate | -518 | |||||
3-Year FCF Growth Rate | -90.4 | |||||
3-Year Book Growth Rate | 372.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.33 | |||||
9-Day RSI | 52.95 | |||||
14-Day RSI | 50.93 | |||||
6-1 Month Momentum % | 18.34 | |||||
12-1 Month Momentum % | -32.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.34 | |||||
Quick Ratio | 0.17 | |||||
Days Inventory | 313.27 | |||||
Days Sales Outstanding | 220.97 | |||||
Days Payable | 673.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.2 | |||||
Shareholder Yield % | -12.35 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.58 | |||||
Operating Margin % | -313.69 | |||||
Net Margin % | -268.44 | |||||
FCF Margin % | -101.22 | |||||
ROE % | -121 | |||||
ROA % | -46.5 | |||||
ROIC % | -47.83 | |||||
ROC (Joel Greenblatt) % | -463.79 | |||||
ROCE % | -78.54 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.4 | |||||
PB Ratio | 9.35 | |||||
EV-to-EBIT | -3.62 | |||||
EV-to-EBITDA | -4.17 | |||||
EV-to-Revenue | 11.71 | |||||
EV-to-FCF | -11.58 | |||||
Earnings Yield (Greenblatt) % | -27.62 | |||||
FCF Yield % | -10.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CS Medica AS Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.655 | ||
EPS (TTM) (€) | -0.142 | ||
Beta | 0 | ||
Volatility % | 97.27 | ||
14-Day RSI | 50.93 | ||
14-Day ATR (€) | 0.068188 | ||
20-Day SMA (€) | 0.4039 | ||
12-1 Month Momentum % | -32.02 | ||
52-Week Range (€) | 0.248 - 0.794 | ||
Shares Outstanding (Mil) | 12.32 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CS Medica AS Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CS Medica AS Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
CS Medica AS Frequently Asked Questions
What is CS Medica AS(FRA:8G8)'s stock price today?
When is next earnings date of CS Medica AS(FRA:8G8)?
Does CS Medica AS(FRA:8G8) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |